An elevated level of TSH might be predictive of differentiated thyroid cancer

Annales d'Endocrinologie

Volumn 72, Issue 6, 2011, Pages 513-521

  Dorange, Anne ^a   Triau, Stéphane ^a   Mucci Hennekinne, Stéphanie ^a   Bizon, Alain ^a   Laboureau Soares, Sandrine ^a   Illouz, Frédéric ^a   Rodien, Patrice ^a,b,c   Rohmer, Vincent ^a,b,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BENIGN TUMOR; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIATED THYROID CANCER; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; THYROID ADENOMA; THYROID CARCINOMA; THYROID DISEASE; THYROID NODULE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TUMOR CALCINOSIS;

ADOLESCENT; ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 83255176697     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.07.032     Document Type: Article

References (45)

1. Mazzaferri E.L., Kloos R.T. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001, 86(4):1447-1463.
2. Hundahl S.A., Fleming I.D., Fremgen A.M., Menck H.R. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995 [see comments]. Cancer 1998, 83(12):2638-2648.
3. Belfiore A., La Rosa G.L., La Porta G.A., Giuffrida D., Milazzo G., Lupo L., et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992, 93(4):363-369.
4. Alexander E.K., Marqusee E., Orcutt J., Benson C.B., Frates M.C., Doubilet P.M., et al. Thyroid nodule shape and prediction of malignancy. Thyroid 2004, 14(11):953-958.
5. Hamming J.F., Goslings B.M., van Steenis G.J., van Ravenswaay Claasen H., Hermans J., van de Velde C.J. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 1990, 150(1):113-116.
6. Bell B., Mazzaferri E.L. Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature. Dig Dis Sci 1993, 38(1):185-190.
7. Solbiati L., Volterrani L., Rizzatto G., Bazzocchi M., Busilacci P., Candiani F., et al. The thyroid gland with low uptake lesions: evaluation by ultrasound. Radiology 1985, 155(1):187-191.
8. Rago T., Vitti P., Chiovato L., Mazzeo S., De Liperi A., Miccoli P., et al. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in " cold" thyroid nodules. Eur J Endocrinol 1998, 138(1):41-46.
9. Illouz F., Rodien P., Saint-Andre J.P., Triau S., Laboureau-Soares S., Dubois S., et al. Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules. Eur J Endocrinol 2007, 156(3):303-308.
10. Pujol P., Daures J.P., Nsakala N., Baldet L., Bringer J., Jaffiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996, 81(12):4318-4323.
11. Boelaert K., Horacek J., Holder R.L., Watkinson J.C., Sheppard M.C., Franklyn J.A. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006, 91(11):4295-4301.
12. Haymart M.R., Glinberg S.L., Liu J., Sippel R.S., Jaume J.C., Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009, 71(3):434-439.
13. Jonklaas J., Nsouli-Maktabi H., Soldin S.J. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 2008, 18(9):943-952.
14. Shaha A.R. TNM classification of thyroid carcinoma. World J Surg 2007, 31(5):879-887.
15. Hamilton T.E., Davis S., Onstad L., Kopecky K.J. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008, 93(4):1224-1230.
16. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007, 28(7):742-762.
17. Carayon P., Thomas-Morvan C., Castanas E., Tubiana M. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 1980, 51(4):915-920.
18. Chang T.C., Kuo S.H., Liaw K.Y., Chang C.C., Chen F.W. Cell kinetics, DNA content and TSH receptor-adenylate cyclase system in differentiated thyroid cancer. Clin Endocrinol (Oxf) 1988, 29(5):477-484.
19. Chia S.-Y., Milas M., Reddy S.K., Siperstein A., Skugor M., Brainard J., et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. J Clin Endocrinol Metab 2007, 92(2):468-475.
20. Shi Y., Zou M., Farid N.R. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Clin Endocrinol (Oxf) 1993, 39(3):269-274.
21. Hoelting T., Tezelman S., Siperstein A.E., Duh Q.Y., Clark O.H. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro. Thyroid 1995, 5(1):35-40.
22. Bourasseau I., Savagner F., Rodien P., Duquenne M., Reynier P., Guyetant S., et al. No evidence of thyrotropin receptor and G(s alpha) gene mutation in high iodine uptake thyroid carcinoma. Thyroid 2000, 10(9):761-765.
23. de Souza Meyer E.L., Dora J.M., Wagner M.S., Maia A.L. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards papillary carcinoma. Clin Endocrinol (Oxf) 2005, 62(6):672-678.
24. Goldberg R.C., Lindsay S., Nichols C.W., Chaikoff I.L. Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131. Cancer Res 1964, 24:35-43.
25. Ross D.S., Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 2006, 91(11):4253-4255.
26. Ain K.B., Taylor K.D. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 1994, 78(5):1097-1102.
27. Gustavsson B., Hermansson A., Andersson A.C., Grimelius L., Bergh J., Westermark B., et al. Decreased growth rate and tumour formation of human anaplastic thyroid carcinoma cells transfected with a human thyrotropin receptor cDNA in NMRI nude mice treated with propylthiouracil. Mol Cell Endocrinol 1996, 121(2):143-151.
28. Fiore E., Rago T., Provenzale M.A., Scutari M., Ugolini C., Basolo F., et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010, 17(1):231-239.
29. Cipolla C., Sandonato L., Graceffa G., Fricano S., Torcivia A., Vieni S., et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005, 71(10):874-878.
30. Larson S.D., Jackson L.N., Riall T.S., Uchida T., Thomas R.P., Qiu S., et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007, 204(5):764-773. [Discussion 773-5].
31. Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997, 275(5302):960-963.
32. Arif S., Blanes A., Diaz-Cano S.J. Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 2002, 41(4):357-362.
33. Kashima K., Yokoyama S., Noguchi S., Murakami N., Yamashita H., Watanabe S., et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998, 8(3):197-202.
34. Hemminki K., Eng C., Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005, 90(10):5747-5753.
35. Henderson B.E., Ross R.K., Pike M.C., Casagrande J.T. Endogenous hormones as a major factor in human cancer. Cancer Res 1982, 42(8):3232-3239.
36. Furlanetto T.W., Nguyen L.Q., Jameson J.L. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999, 140(12):5705-5711.
37. Boccabella A.V., Alger E.A. Influence of estradiol on thyroid: serum radioiodide concentration ratios of gonadectomized and hypophysectomized rats. Endocrinology 1964, 74:680-688.
38. Pelletier G. Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol 2000, 15(4):1261-1270.
39. Kim E.Y., Kim W.G., Kim W.B., Kim T.Y., Kim J.M., Ryu J.-S., et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2009, 71(4):581-586.
40. Salmaslioĝlu A., Erbil Y., Dural C., Işsever H., Kapran Y., Ozarmaĝan S., et al. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg 2008, 32(9):1948-1954.
41. Frates M.C., Benson C.B., Charboneau J.W., Cibas E.S., Clark O.H., Coleman B.G., et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005, 237(3):794-800.
42. Wienke J.R., Chong W.K., Fielding J.R., Zou K.H., Mittelstaedt C.A. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med 2003, 22(10):1027-1031.
43. Papini E., Guglielmi R., Bianchini A., Crescenzi A., Taccogna S., Nardi F., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87(5):1941-1946.
44. Kakkos S.K., Scopa C.D., Chalmoukis A.K., Karachalios D.A., Spiliotis J.D., Harkoftakis J.G., et al. Relative risk of cancer in sonographically detected thyroid nodules with calcifications. J Clin Ultrasound 2000, 28(7):347-352.
45. Khoo M.L.C., Asa S.L., Witterick I.J., Freeman J.L. Thyroid calcification and its association with thyroid carcinoma. Head Neck 2002, 24(7):651-655.